Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database

Regulatory Toxicology and Pharmacology

Volumn 61, Issue 2, 2011, Pages 154-160

  Kim, JaYoung ^a   Kim, Munsin ^a   Ha, Ji Hye ^a   Jang, Junghoon ^a   Hwang, Myungsil ^a   Lee, Byung Koo ^b   Chung, Myeon Woo ^a   Yoo, Tae Moo ^a   Kim, Myung Jung ^a  

^a Korea Food and Drug Administration   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Health insurance claims database; Methylphenidate; National spontaneous reporting database; Signal detection; WHO database

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD TOXICITY; BREAST DISEASE; CARDIOTOXICITY; CHI SQUARE TEST; CHILD; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DATA BASE; DATA MINING; DRUG SURVEILLANCE PROGRAM; ENDOCRINE DISEASE; EYE DISEASE; GASTROINTESTINAL DISEASE; HEALTH INSURANCE; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFORMATION COMPONENT; KOREA; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEUROTOXICITY; NUTRITIONAL DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL REPORTING RATIO; REPORTING ODDS RATIO; REPRODUCTIVE TOXICITY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SCHOOL CHILD; SIGNAL DETECTION; SKIN DISEASE; STATISTICAL ANALYSIS; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA MINING; DATABASES, FACTUAL; DRUG TOXICITY; HUMANS; INSURANCE CLAIM REPORTING; METHYLPHENIDATE; ODDS RATIO; PHARMACOVIGILANCE; REPUBLIC OF KOREA; RESEARCH REPORT; RISK; SIGNAL DETECTION, PSYCHOLOGICAL;

EID: 80053612042     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.03.015     Document Type: Article

References (25)

1. Alsheikh-Ali A.A., et al. The safety of rosuvastatin as used in common clinical practice. a postmarketing analysis. Circulation 2005, 111:3051-3057.
2. Bate A., et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur. J. Clin. Pharmacol. 1998, 54:315-321.
3. Choi N.K., et al. Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database. Pharmacoepidemiol. Drug Saf. 2010, 19:238-246.
4. Evans S.J., et al. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol. Drug Saf. 2001, 10:483-486.
5. Gau S.S., et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J. Clin. Psychiatry 2008, 69:131-140.
6. Gould A.L. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol. Drug Saf. 2003, 12:559-574.
7. Hauben M., Zhou X. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf. 2003, 26:159-186.
8. HIRA, Health Insurance Review and Assessment Service 2005, HIRA notice 2005-40.
9. KFDA, Korea Food and Drug Administration, 2008a, Regulation on the management of safety information of the drugs, etc., KFDA notice No. 2008-40.
10. KFDA, Korea Food and Drug Administration, 2008b, Regulation on the reevaluation of drugs, KFDA notice No. 2008-48.
11. KFDA, Korea Food and Drug Administration, 2009, Regulation on the reexamination of new drugs, KFDA notice No. 2009-46.
12. Lee S.I., et al. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:210-216.
13. Li C., et al. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China. Pharmacoepidemiol. Drug Saf. 2008, 17:593-600.
14. Lindquist M., et al. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf. 2000, 23:533-542.
15. Park, B. J., et al., 2003. Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database Seoul National University.
16. Rothman, K. J., 2002. Epidemiology: an introduction. Oxford University Press New York.
17. Sanchez-Matienzo D., et al. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clin. Ther. 2006, 28:1123-1132.
18. Shin J.-S. The present situation and direction of improvement of post-marketing Surveillance in Korea. J. Korean Soc. Pharm. Regul. Sci. 2006, 1:39-42.
19. Tuan N.T., Nicklas T.A. Age, sex and ethnic differences in the prevalence of underweight and overweight, defined by using the CDC and IOTF cut points in Asian children. Eur. J. Clin. Nutr. 2009, 63:1305-1312.
20. USFDA, United States Food and Drug Administration, 2007, FDA Press Release, Accessed Mar 20, 2010.
21. van Puijenbroek E., et al. Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions. Drug Saf. 2003, 26:293-301.
22. van Puijenbroek E.P., et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol. Drug Saf. 2002, 11:3-10.
23. WHO-UMC, World Health Organization-Uppsala Monitoring Centre, 2010, WHO Programme for International Drug Monitoring, Accessed Mar 20, 2010.
24. WHO, World Health Organization, 2002. The importance of pharmacovigilance safety monitoring of medicinal products.
25. Zhang A., et al. Racial differences in growth patterns of children assessed on the basis of bone age. Radiology 2009, 250:228-235.